EpiPen Rival Heads Back To Market After kaléo Retools With ‘100% Automated’ Production

Given US FDA’s strict requirements for generic combination products, brand competitors to Mylan’s pricey epinephrine auto-injector such as kaléo’s Auvi-Q might be the best that buyers can expect for a while.

More from Drug Safety

More from Pink Sheet